TABLE 1

Treatments and outcomes of DAH in 7 cSLE patients

PatientImmunosuppressive TherapiesOther TherapiesOxygen RequirementLength of Follow-up, y
1IVMP, AZANC2
2IVMP, CYCMV5
3PRED, CYC, RTXMV0.5
4IVMP, MTX, RTX, IVIGPLEXMV2.5
5IVMP, CYCNC2.75
6IVMP, CYC, RTXMVLost to follow-up
7IVMP, CYC, IVIGPLEXMVaDied 22 d after admission
  • AZA, azathioprine; CYC, cyclophosphamide; IVIG, intravenous immunoglobulin; IVMP, intravenous methylprednisolone; MTX, methotrexate; PLEX; plasma exchange; PRED, prednisone; RTX, rituximab.

  • a Required oscillatory support.